- Home
- / Hester Biosciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Hester Biosciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
₹2.3 B
FY, 2022
CreditSafe score
?
Score changed on Jun 10, 2023
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial statements
| INR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|---|---|
| Revenue | 1.3B | 1.8B | 1.7B | 2.0B | 2.3B |
| Cost of goods sold | 242.7M | 345.5M | 238.5M | 528.1M | 661.1M |
| Gross profit | 1.1B | 1.5B | 1.6B | 1.6B | 1.8B |
| Gross profit margin, % | 85.3% | 84.9% | 95.5% | 83.8% | 78.1% |
| Operating expense total | 640.3M | 753.3M | 1.0B | 924.7M | 1.1B |
| Depreciation and amortization | 96.6M | 117.6M | 132.3M | 133.1M | 165.8M |
| EBITDA | 499.1M | 751.5M | 603.8M | 724.5M | 725.2M |
| EBITDA margin, % | 37.6% | 42.4% | 35.2% | 36.8% | 31.4% |
| EBIT | 398.8M | 633.9M | 471.5M | 558.2M | 554.7M |
| EBIT margin, % | 30.1% | 35.8% | 27.5% | 28.4% | 24.0% |
| Interest income | 810.0K | 1.5M | 3.7M | 12.9M | 19.0M |
| Interest expense | 40.4M | 66.3M | 76.7M | 66.0M | 35.3M |
| Pre tax profit | 361.2M | 568.6M | 413.3M | 501.0M | 535.0M |
| Income tax expense | 130.5M | 161.6M | 103.2M | 154.1M | 140.2M |
| Net Income | 230.7M | 406.9M | 310.0M | 347.0M | 394.8M |